Kyle J. Popovich, MD, MS; David P. Calfee, MD; Payal K. Patel, MD, MPH; Shelby Lassiter, BSN, RN, CPHQ; Andrew J. Rolle, MPH; Louella Hung, MPH; Sanjay Saint, MD, MPH; Vineet Chopra, MD, MSc
Disclaimer: The findings and conclusions in this report are those of the authors and do not represent the official position of the CDC, the American Hospital Association, or the Department of Veterans Affairs.
Acknowledgment: The authors thank the HRET Health Care-Associated Infection team, as well as the National Program Team and all members of the CDC STRIVE collaborative.
Disclosures: Dr. Popovich reports personal fees from CDC contract with HRET during the conduct of the study. Dr. Calfee reports a CDC contract with the HRET, which subcontracted with Weill Cornell Medical College, during the conduct of the study. Dr. Patel, Dr. Saint, and Dr. Chopra report a contract from the CDC with the HRET, which subcontracted with the University of Michigan to support faculty/staff effort for this contract, during the conduct of the study. Dr. Saint also reports personal fees from Doximity and Jvion outside the submitted work. Ms. Lassiter, Mr. Rolle, and Ms. Hung report a CDC contract with HRET during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3529.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Corresponding Author: Kyle J. Popovich, MD, MS, Rush University, 600 South Paulina, Suite 143, Chicago, IL 60612; e-mail, Kyle_popovich@rush.edu.
Current Author Addresses: Dr. Popovich: Rush University, 600 South Paulina, Suite 143, Chicago, IL 60612.
Dr. Calfee: Weill Cornell Medicine, 525 East 68th Street, Box 265, New York, NY 10065.
Dr. Patel: VA Ann Arbor Healthcare System, 111-I, 2215 Fuller Road, Ann Arbor, MI 48105.
Ms. Lassiter, Mr. Rolle, and Ms. Hung: Center for Health Innovation, American Hospital Association, 155 North Wacker Drive, Suite 400, Chicago, IL 60606.
Drs. Saint and Chopra: Department of Internal Medicine, University of Michigan, 2800 Plymouth Road, Building 16, Room 430W, Ann Arbor, MI 48109-2800.
Author Contributions: Conception and design: K.J. Popovich, P.K. Patel, A.J. Rolle, L. Hung, S. Saint, V. Chopra.
Analysis and interpretation of the data: K.J. Popovich, P.K. Patel.
Drafting of the article: K.J. Popovich, L. Hung, V. Chopra.
Critical revision of the article for important intellectual content: K.J. Popovich, D.P. Calfee, P.K. Patel, A.J. Rolle, L. Hung, S. Saint, V. Chopra.
Final approval of the article: K.J. Popovich, D.P. Calfee, P.K. Patel, S. Lassiter, A.J. Rolle, L. Hung, S. Saint, V. Chopra.
Obtaining of funding: S. Saint, V. Chopra.
Administrative, technical, or logistic support: D.P. Calfee, S. Lassiter, L. Hung, V. Chopra.
Collection and assembly of data: K.J. Popovich.
Overall flow of the CDC STRIVE program.
CDC = Centers for Disease Control and Prevention; STRIVE = States Targeting Reduction in Infections via Engagement.
Table. Characteristics of Hospitals Participating in the STRIVE Program
States that enrolled with the STRIVE program.
In total, 443 hospitals from 28 states and the District of Columbia participated. Recruitment occurred as follows: cohort 1 (June 2016 to April 2017), cohort 2 (November 2016 to October 2017), cohort 3 (April 2017 to March 2018), and cohort 4 (June 2017 to May 2018). Hashing indicates states that participated in more than 1 cohort. STRIVE = States Targeting Reduction in Infections via Engagement.
Education and engagement interventions implemented for participating hospitals.
CDC = Centers for Disease Control and Prevention.
Appendix Table. Overview of the 51 Web-Based Learning Modules Developed for the STRIVE Program
Popovich KJ, Calfee DP, Patel PK, et al. The Centers for Disease Control and Prevention STRIVE Initiative: Construction of a National Program to Reduce Health Care–Associated Infections at the Local Level. Ann Intern Med. 2019;171:S2–S6. doi: https://doi.org/10.7326/M18-3529
Download citation file:
Published: Ann Intern Med. 2019;171(7_Supplement):S2-S6.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use